Neutralizing potency of COVID-19 vaccines against the SARS-CoV-2 Omicron (B.1.1.529) variant.

Lippi, Giuseppe; Mattiuzzi, Camilla; Henry, Brandon M

Lippi, Giuseppe; Mattiuzzi, Camilla; Henry, Brandon M.

Lippi G; School of Medicine, Section of Clinical Biochemistry, University of Verona, Verona, Italy.
Mattiuzzi C; Service of Clinical Governance, Provincial Agency for Social and Sanitary Services, Trento, Italy.
Henry BM; Clinical Laboratory, Division of Nephrology and Hypertension, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.

J Med Virol ; 94(5): 1799-1802, 2022 05.

Article in English | MEDLINE | ID: covidwho-1606178

Subject(s)

COVID-19; SARS-CoV-2; COVID-19/prevention & control; COVID-19 Vaccines; Humans; Mutation; SARS-CoV-2/genetics; Spike Glycoprotein, Coronavirus/genetics

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Topics: Vaccines / Variants Limits: Humans Language: English Journal: J Med Virol Year: 2022 Document Type: Article Affiliation country: Jmv.27575

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google